Provided by Tiger Trade Technology Pte. Ltd.

Amylyx Pharmaceuticals

34.74
-2.4400-6.56%
Pre-market: 34.08-0.6605-1.90%04:40 EDT
Volume:1.36M
Turnover:48.13M
Market Cap:3.86B
PE:-24.28
High:37.68
Open:36.78
Low:34.48
Close:37.18
52wk High:41.14
52wk Low:9.15
Shares:111.19M
Float Shares:109.51M
Volume Ratio:0.44
T/O Rate:1.24%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.4309
EPS(LYR):-1.5305
ROE:-74.73%
ROA:-44.13%
PB:16.15
PE(LYR):-22.70

Loading ...

Aug 20, 2026

Major Issues Report

Form 8-K - Current report
Aug 18, 2026

Major Issues Report

Form 8-K - Current report
Aug 18, 2026

Major Issues Report

Form 8-K - Current report
Aug 06, 2026

Major Issues Report

Form 8-K - Current report
Aug 06, 2026

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 09, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 04, 2026

Major Issues Report

Form 8-K - Current report
May 15, 2026

Beneficial Ownership Change

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
May 07, 2026

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 07, 2026

Major Issues Report

Form 8-K - Current report
Mar 24, 2026

Major Issues Report

Form 8-K - Current report
Mar 03, 2026

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Mar 03, 2026

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 03, 2026

Major Issues Report

Form 8-K - Current report
Mar 03, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 03, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 03, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 03, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 03, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 24, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities